Industry Standing Group
Industry Standing Group
Industry Standing Group
Human medicines European public assessment report (EPAR): Stivarga, regorafenib, Date of authorisation: 26/08/2013, Revision: 22, Status: Authorised
Dear EFIM Colleagues,
We are pleased to invite you to an upcoming webinar organized by the EFIM Young Internists (YI) Section and the Telemedicine Working Group.
This session will focus on "(Un)expected Fundamentals of Medicine and Artificial Intelligence" and will feature Dr. Marco Montagna from Vita-Salute San Raffaele University.
The discussion will be moderated by Dr. Ismael Said Criado, Chair of the Telemedicine Working Group, and Dr. Mario Dadone from the University of Palermo.
Date: 18 February 2025
PRIME: priority medicines
Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 27-30 January 2025
Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - 4 February 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 4 February 2025, 11:00 (CET) to 4 February 2025, 11:45 (CET)
Procurement
List of medicines currently in PRIME scheme
Training on human variations web-based electronic application form (eAF) functionalities for non-CAPs variations, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 February 2025, 10:30 (CET) to 11 February 2025, 12:30 (CET)
European Shortages Monitoring (ESMP) - Question and answer clinic for marketing authorisation holders on shortage reporting via ESMP, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 February 2025, 10:00 (CET) to 25 February 2025, 11:00 (CET)